Trisalus Life Sciences (TLSI): Director bought, ~$1M

~$1M
Approx. value · 244K sh @ $4.10: 787K
Holds after · shares reported

Traded: Feb 23, 2026
Filed: Feb 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
Feb 3, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 3, 2026, Dr. Arjun “JJ” Desai informed the Board of Directors (the “Board”) of TriSalus Life Sciences, Inc. (the “Company”) of his decision to resign from his position as a member of the Board, effective immediately.”
Feb 19, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
Feb 23, 2026 · this disclosureInsider · 10 days before resultsDirector purchased ~$1M of TLSI shares in the open market

What came next

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Trisalus Life Sciences

For Trisalus Life Sciences, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TLSI page.

Other recent filings by Michael P Stansky, Director

The full history of Michael P Stansky, Director is on the profile page.

Other disclosures at Trisalus Life Sciences

Everything OQRO holds on this company is on its TLSI page.

Trisalus Life Sciences (TLSI)Director bought ~$1M